Infectious Diseases

Improving influenza vaccination coverage is important for all children, but some are at greater risk for poorer outcomes. A review examines whether interventions can improve vaccine coverage.

Survey suggests many will continue pandemic precautions after the crisis ends.

The loneliness and isolation of the pandemic has wreaked havoc on the mental health of many. A report examines whether this translated into more suicidal ideation and behavior.

Traditional flu season has collided with the pandemic. Here’s what you need to know.

A report examines if the influenza and pneumococcal vaccine has a protective effect against COVID-19.

The American Academy of Pediatrics (AAP) has issued initial guidance for COVID-19 vaccination in pediatrics.

It is more important than ever for health care professionals to remember that overprescribing these drugs can have life-threatening consequences.

Does using methylprednisolone along with intravenous immunoglobulins improve fever outcomes for multisystem inflammatory syndrome in children (MIS-C) cases? A French investigation offers some answers.

Cytomegalovirus (CMV) is linked to hearing loss in affected children. An investigation looks into whether the viral load impacts this risk.

A pediatric infectious disease specialist discusses where we are at with children's vaccines for COVID-19.

Moderna has announced further research into whether a booster shot could provide additional protection with new COVID-19 variants.

An investigation looks at the neurological manifestations of COVID-19.

With the good news of the 2 successful vaccines and a much greater understanding of COVID-19, it is time to consider what lies ahead for 2021.

The COVID-19 pandemic has had a severe negative toll on the mental health of many children. Here are some tips to help children achieve better psychological well-being.

The Biden transition team has named more members of the COVID-19 response team, including pediatrician and lawyer Dr. Kessler.

What we knew about COVID-19 when the pandemic began, what we know now.

The American Academy of Pediatrics (AAP) has updated their safety guidance for in-person schooling during the pandemic.

The Infectious Diseases Society of America (ISDA) has updated recommendations for COVID-19 diagnostic testing.

The COVID-19 vaccine, and the speed at which it was developed, is the medical breakthrough of our lifetimes.

Believe it or not, there was a sunny side to 2020.

A look at how we learned to protect ourselves and our patients from COVID-19 over the past year.

Several reports coming out of the United Kingdom are suggesting that the newest variant of COVID-19 might be more infectious for children.

The National Institutes of Health award 8 research grants to develop ways to identify children at high risk for multi system inflammatory syndrome I children (MIS-C).

Social distancing measures may have helped slow the spread of COVID-19 in the early days of the pandemic, but an investigation indicates an unintended and potentially problematic consequence: a decline in vaccination.

Many changes have happened in medical care to protect patients and prevent further spread of COVID-19. An investigation looks at whether newborns can be roomed-in with and breastfed by mothers who have been infected.

One of the chief concerns with schools being closed was how it would impact children who need certain services or lacked access to basic needs such as food and shelter. A study looks into how state-level guidance addressed these concerns when schools reopened in the fall.

The NIH starts observational study of COVID-19 and MIS-C in children

Diagnosing multisystem inflammatory syndrome in children (MIS-C) has not always been easy. A new report indicates that mucocutaneous findings might aid in diagnosis.

The American Academy of Pediatrics (AAP) has updated their guidance on participating in sports during the COVID-19 pandemic.

Following the green light from the vaccine advisory committee, the US Food and Drug Administration has given emergency use authorization for the Pfizer/BioNTech COVID-19 vaccine, making it the first vaccine for COVID-19 approved for use in the United States.